Levett Benjamin A, Chandra Avinash, Jiang Jessica, Koohi Nehzat, Sharrad Dale, Core Lucy B, Johnson Jeremy C S, Tutton Madison, Green Tim, Jayakody Dona M P, Yu Jin-Tai, Leroi Iracema, Marshall Charles R, Bamiou Doris-Eva, Hardy Chris J D, Warren Jason D
Dementia Research Centre, UCL Institute of Neurology, Queen Square, UCL, 8-11 Queen Square, London, WC1N 3AR, UK.
Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
J Neurol. 2025 May 16;272(6):402. doi: 10.1007/s00415-025-13140-x.
The relationship between hearing impairment and dementia has attracted significant attention, the 2024 Lancet Commission report identifying hearing loss as the largest modifiable risk factor for dementia from mid-life. The nature of this linkage between dementia and hearing remains unclear and is likely to be complex. In principle, hearing impairment could cause (directly promote), catalyze (amplify) or be a consequence of neurodegenerative pathology and cognitive decline. Here we use this framework to examine different lines of evidence for the association between hearing impairment and dementia, and consider how this evidence speaks to potential mechanisms and treatment implications. We conclude by considering practical clinical implications for management of patients with hearing impairment and dementia, the potential role for central hearing tests as 'auditory biomarkers' of dementia, and the need for further collaborative and mechanistically motivated research in this area.
听力障碍与痴呆症之间的关系已引起广泛关注,《柳叶刀》2024年委员会报告指出,听力损失是中年后痴呆症最大的可改变风险因素。痴呆症与听力之间这种联系的本质尚不清楚,而且可能很复杂。原则上,听力障碍可能是神经退行性病变和认知衰退的原因(直接促成)、催化剂(放大作用)或结果。在此,我们运用这一框架来审视听力障碍与痴呆症关联的不同证据线索,并思考这些证据如何阐释潜在机制及对治疗的启示。我们通过思考对听力障碍和痴呆症患者管理的实际临床意义、中枢听力测试作为痴呆症“听觉生物标志物”的潜在作用,以及该领域进一步开展协作性和基于机制研究的必要性来得出结论。